Renal Allografts at Risk After ICIs for Subsequent Cancer Renal Allografts at Risk After ICIs for Subsequent Cancer

The risk for acute rejection and subsequent graft loss is high when kidney transplant recipients receive an immune checkpoint inhibitor (ICI) for subsequent cancer, new research shows.Medscape Medical News
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Nephrology News Source Type: news